All News

Pharmacy Times spoke with Tomas Villanueva, DO, MBA, FACPE, SFHM, practicing health care provider, and associate vice president for clinical resources at Vizient, about what pharmacists should know about vaccine hesitancy in general.

The ability of pharmacists in the United States to dispense naloxone in many states could be a considerable help for this public health problem.

Catherine Duggan, FRPharmS, CEO of International Pharmaceutical Federation, discusses the role and the authorities of the pharmacist internationally, and the effect the pandemic has had on that role globally.

The approval is based on a pair of Phase 3 studies in which oral ibrexafungerp demonstrated efficacy and a favorable tolerability profile in women with vulvovaginal candidiasis.

Frequent prostate-specific antigen screenings may lower the risk of metastasis at the time of diagnosis and lower mortality risk from prostate cancer among younger African American men.

Although many health systems offer wellness program for their staff, awareness and utilization of these services remains low.

Rates of death among patients with breast cancer due to any cause were 31% higher in states with Medicaid income eligibility limits no greater than 50% of the federal poverty level.

The once-daily, oral atypical antipsychotic medication has the same established antipsychotic efficacy of olanzapine with less weight gain.

Research could allow the study of long-term HIV infections and the testing of new curative therapies.

Launched in 2020, a diabetes pilot program resulted in a significant improvement in patient outcomes for those enrolled.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Study examines whether implementing an oral care protocol for general practitioners can improve patient-centered outcomes for individuals with type 2 diabetes.

A recent study also found that weight loss may decrease dependence on medication.

An overview of continuing education and advanced training offerings for pharmacy technicians and what is on the horizon for 2021.

The tool measures brain health based on cognitive performance and may be used in the future to predict the likelihood that an individual will develop memory and thinking problems as they age.

The approval represents the first and only oral sphingosine 1-phosphate receptor modulator indicated for adults with moderately to severely active ulcerative colitis.

Not only are pharmacists drug experts, but the pandemic demonstrated that they can also perform COVID-19 testing and vaccinations alongside physicians and other health care providers.

Lung cancer, the most common cancer type with the highest mortality, can largely be categorized by the genetic mutations that cause it.

The body’s relationship with gut bacteria emerges after birth and in early infancy, during important immunological and physiological development.

Study indicates that teens and adults who use e-cigarettes have increased odds of developing asthma and having asthma attacks.

According to the study authors, 9% of the children receiving the combination therapy did not respond to treatment, compared to 51% of children receiving IVIG alone.

This is the first and only oncology immunotherapy to show positive phase 3 results in the adjuvant lung cancer setting.

As pharmacy professionals battle with their own challenges regarding mental health, the optimal role of psychiatric pharmacists is yet to be defined.

Both health care providers and the general public said skin dryness is a major obstacle for consistent hand hygiene practices.

Previous research indicates that probiotics decrease upper respiratory infections in healthy adults and children, but limited data exist on older, overweight, and people with obesity.

Pharmacy Times spoke with Tomas Villanueva, DO, MBA, FACPE, SFHM, practicing health care provider, and associate vice president for clinical resources at Vizient, about the value of the pharmacist in addressing vaccine hesitancy.

In March, the FDA approved dasiglucagon (Zegalogue) for the treatment of severe hypoglycemia in people with diabetes aged 6 years or older.